HIV/AIDS Seroreversion
HIV antibody seroreversion does not indicate viral eradication
Published in AIDS Weekly, April 3rd, 2006
"We assessed human immunodeficiency virus (HIV) antibody seroreversion among individuals initiating antiretroviral therapy (ART) during acute/early HIV infection and determined whether seroreversion was associated with loss of cytotoxic T lymphocyte responses.
"Subjects in a cohort with acute/early HIV infection ({{<=}}12 months into infection) who initiated ART within 28 days after study entry and maintained HIV type 1 ribonucleic acid levels of {{<=}}500 copies/mL for 124 weeks were selected," scientists writing in the journal Clinical Infectious Diseases report.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-04-03)
More Articles from AIDS Weekly
- HIV/AIDS Epidemiology
HIV-1 non-B subtype transmission continues in the U.K. - HIV/AIDS Genetics & Genomics
HIV disease progression rate influenced by HLA-B locus polymorphism - HIV/AIDS HAART
HIV-1 RNA helps guide patient selection for HAART in resource-poor settings - Proteomics
Interferon-alpha mediates anti-HIV activity via APOBEC3G induction - Adverse Drug Reaction
KS aggravated by rituximab when used to treat HIV-related multicentric Castleman disease - Clinical Trials
Boehringer Ingelheim closes one arm of Aptivus (tipranavir) study - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
